Kubeš, J.; Sláviková, S.; Vítek, P.; Haas, A.; Ondrová, B.; Dedečková, K.; Andrlík, M.; Domanský, M.; Jiránková, K.; Schlencová, V.;
et al. 5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis. Cancers 2023, 15, 4571.
https://doi.org/10.3390/cancers15184571
AMA Style
Kubeš J, Sláviková S, Vítek P, Haas A, Ondrová B, Dedečková K, Andrlík M, Domanský M, Jiránková K, Schlencová V,
et al. 5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis. Cancers. 2023; 15(18):4571.
https://doi.org/10.3390/cancers15184571
Chicago/Turabian Style
Kubeš, Jiri, Silvia Sláviková, Pavel Vítek, Alexandra Haas, Barbora Ondrová, Kateřina Dedečková, Michal Andrlík, Martin Domanský, Kateřina Jiránková, Veronika Schlencová,
and et al. 2023. "5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis" Cancers 15, no. 18: 4571.
https://doi.org/10.3390/cancers15184571
APA Style
Kubeš, J., Sláviková, S., Vítek, P., Haas, A., Ondrová, B., Dedečková, K., Andrlík, M., Domanský, M., Jiránková, K., Schlencová, V., Harazimová, A., Turková, B., Doležal, T., Al-Hamami, S. F. A., & Vondráček, V.
(2023). 5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis. Cancers, 15(18), 4571.
https://doi.org/10.3390/cancers15184571